Abstract:Abstract The emergence and ensuing dominance of COVID-19 on the world stage has emphasized the urgency of efficient animal models for the development of therapeutics and assessment of immune responses to SARS-CoV-2 infection. Shortcomings of current animal models for SARS-CoV-2 include limited lower respiratory disease, divergence from clinical COVID-19 disease, and requirements for host genetic modifications to permit infection. This study validates a feline model for SARS-CoV-2 infection that results in clinical disease and histopathologic lesions consistent with severe COVID-19 in humans. Intra-tracheal inoculation of concentrated SARS-CoV-2 caused infected cats to develop clinical disease consistent with that observed in the early exudative phase of COVID-19. A novel clinical scoring system for feline respiratory disease was developed and utilized, documenting a significant degree of lethargy, fever, dyspnea, and dry cough in infected cats. In addition, histopathologic pulmonary lesions such as diffuse alveolar damage, hyaline membrane formation, fibrin deposition, and proteinaceous exudates were observed due to SARS-CoV-2 infection, imitating lesions identified in people hospitalized with ARDS from COVID-19. A significant correlation exists between the degree of clinical disease identified in infected cats and pulmonary lesions. Viral loads and ACE2 expression were quantified in nasal turbinates, distal trachea, lung, and various other organs. Natural ACE2 expression, paired with clinicopathologic correlates between this feline model and human COVID-19, encourage use of this model for future translational studies. Author Summary Identifying an ideal animal model to study COVID-19 has been difficult, and current models come with challenges that restrict their potential in translational studies. Few lab animals naturally express the receptors necessary for viral infection (ACE2), and many fail to manifest clinical signs or pathology similar to that seen in humans. Other models (non-human primates, mink) are ideal for disease and transmission studies, but are restricted by cost, husbandry challenges, and scarce availability. Alternatively, cats naturally express ACE2 receptors, are naturally infected with SARS-CoV-2 and can transmit virus from cat-to-cat. Prior to this study, cats infected by oral/nasal routes have not displayed significant clinical disease or lung pathology. However, we demonstrate that direct inoculation of concentrated SARS-CoV-2 virus in the trachea of cats induces analogous clinical and pathologic features to hospitalized patients with acute COVID-19. Our results show that infected cats exhibit significant clinical signs during experimental infection (coughing, increased respiratory effort, lethargy, and fever) and exhibit extensive lung lesions that mimic severe COVID-19 pathology such as diffuse alveolar damage and hyaline membrane formation – highlighting the immeasurable potential for this feline model to address translational approaches for COVID-19 and to better understand the role of cats in transmission and disease.

Feline immunodeficiency virus model to study human immunodeficiency virus/acquired immune deficiency syndrome conditions

Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats

Early Stages of Feline Immunodeficiency Virus-Infection in Lymph-Nodes and Spleen

Experimental transmission and pathogenesis of immunodeficiency syndrome in cats

Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection

Suppression of Immunodeficiency Virus-Associated Neural Damage by the P75 Neurotrophin Receptor Ligand, LM11A-31, in an in Vitro Feline Model

Impacts of Antiretroviral Therapy on the Oral Microbiome and Periodontal Health of Feline Immunodeficiency Virus Positive Cats

Methods for assessing feline immunodeficiency virus infection, infectivity and purification

Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?

Cerebrospinal Fluid is an Efficient Route for Establishing Brain Infection with Feline Immunodeficiency Virus and Transfering Infectious Virus to the Periphery

Compartmentalization and Evolution of Feline Immunodeficiency Virus Between the Central Nervous System and Periphery Following Intracerebroventricular or Systemic Inoculation

Acute virulent infection with feline immunodeficiency virus (FIV) results in lymphomagenesis via an indirect mechanism

Shedding of Feline Immunodeficiency Virus in Semen of Domestic Cats During Acute Infection.

Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management

Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans

Molecular survey of feline immunodeficiency virus (FIV) infection in Namibian cats

Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats

Study of feline immunodeficiency virus prevalence and expert opinions on standards of care

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha

Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134

Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines